Dr. Steven Walter Coutras, MD

Dr. Coutras practices at Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia.

Dr. Coutras' NPI, 1417953084, was assigned on June 28, 2005. Dr. Coutras graduated from Georgetown University School Of Medicine in 1981. Dr. Coutras holds West Virginia license 18329.

Dr. Coutras' primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD, at 33 Medical Center Dr, Morgantown, WV 26505.

Dr. Coutras' primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia. Dr. Coutras is also affiliated with J.W. Ruby Memorial Hospital. The medical group on file is University Health Associates.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Coutras practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Coutras' primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Coutras is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Coutras' licenses on file in 6 states: West Virginia, New Hampshire, Pennsylvania, Virginia, Maryland and North Carolina.

Dmand AI lists chronic nasal allergies and larynx and vocal cord disease among the conditions Dr. Coutras treats.

CMS data shows 102 Medicare services from Dr. Coutras across 3 procedure codes in 2024, for 92 Medicare patients. Medicare paid $8,167 for them.

CMS counts 92 Medicare patients who saw Dr. Coutras in 2024. The largest group is 65 to 74, with 56 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Coutras' median patient age at 46, with 40% women.

In 2024, Dr. Coutras wrote 51 Medicare Part D claims for 23 patients. 100% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $109 in total drug cost. In 2023, CMS named 29 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Coutras for performance year 2024, reported through an alternative payment model (APM). Dr. Coutras accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 20 papers to Dr. Coutras, published from 2018 to 2025. 2022 was the busiest year, with 5. The most frequent topics are Sleep Apnea, Obstructive, Adenoidectomy and Endoscopy. Dr. Coutras has published most often in Ann Otol Rhinol Laryngol. Dr. Coutras' most frequent co-authors are Michele M. Carr, DDS, MD, PhD, Habib George Zalzal and Adrian Williamson, MD.

CMS Open Payments shows 18 general payments to Dr. Coutras from 8 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 70% of the total. Smith & Nephew, Inc. paid the most, $1,125.

Dmand AI lists 2 awards for Dr. Coutras, most recently ACS Fellow in 2013.

Dr. Coutras graduated from Georgetown University School Of Medicine in 1981. Dr. Coutras is a member of American Academy of Otolaryngic Allergy, NHS, AASM and ACS.

Dr. Coutras is in network with 20 carriers, including Aetna, Highmark and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.